Overview of Esophageal Motility Disorders

Sep 6, 2024

Esophageal Motility Disorders

Introduction

  • Esophageal motility disorders: Issues with the esophagus's ability to move food and fluids to the stomach.
  • Disorders involve malfunctioning of either nerves innervating the esophagus or the esophageal muscles.
  • Common symptom: Dysphagia (difficulty swallowing).
    • Affects both solids and liquids.

Mechanism

  • Nerve Dysfunction: Affects nitric oxide and vasoactive intestinal peptide release.
    • These chemicals relax the esophageal muscles.
    • Damage leads to decreased relaxation, resulting in high muscle tone.
  • Muscle Dysfunction: Issues in the esophageal muscle itself.

Complications

  • Esophageal Cancer Risk: Particularly increased in conditions like achalasia and esophageal scleroderma.
  • Aspiration Risk: Due to inability to move food/fluid properly, leading to aspiration into the airway.

Types of Esophageal Motility Disorders

  1. Achalasia

    • Caused by damage to the myenteric plexus.
    • Symptoms: Increased lower esophageal sphincter tone, decreased mid/distal esophageal motility.
    • Secondary cause: Trypanosoma cruzi (can cause megaesophagus).
  2. Diffuse Esophageal Spasm

    • Normal lower esophageal sphincter tone, but high and disorganized motility.
    • Symptoms include dysphagia and intense chest pain.
  3. Esophageal Scleroderma

    • Involves atrophy and fibrosis of the esophagus.
    • Symptoms include decreased esophageal sphincter tone and motility.
    • Associated with CREST syndrome (Calcinosis, Raynaud's phenomenon, Esophageal dysmotility, Sclerodactyly, Telangiectasia).

Diagnostic Approach

  • Barium Swallow

    • Achalasia: Bird's beak appearance.
    • Diffuse esophageal spasm: Corkscrew appearance.
  • EGD with Biopsy

    • Used to rule out malignancy, especially in achalasia.
  • Manometry (Gold Standard)

    • Measures pressures and contractions at different esophageal levels.
    • Achalasia: Low mid/distal tone, high lower esophageal sphincter tone.
    • Diffuse spasm: High uncoordinated contraction.
    • Scleroderma: Poor contractility.

Treatment

Achalasia

  • Medications: Calcium channel blockers (e.g., amlodipine), nitrates (e.g., isosorbide dinitrate).
  • Severe Cases:
    • Pneumatic Dilation: Balloon inflation to open lower esophageal sphincter.
    • Heller's Myotomy: Surgical cutting to reduce sphincter tone.
  • Alternative: Botulinum toxin injections.

Diffuse Esophageal Spasm

  • Medications: Calcium channel blockers and nitrates to relax the esophagus.

Esophageal Scleroderma

  • Management: Use of PPIs to prevent esophagitis. No effective surgical options due to systemic nature.

Key Points

  • Achalasia benefits more from surgical interventions (pneumatic dilation, Heller’s myotomy).
  • Diffuse esophageal spasm responds well to medical therapy.
  • Scleroderma primarily managed with PPIs and symptomatic treatment.